Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
InsightRX, a leader in precision dosing AI solutions, has been recognized in the 2025 KLAS Emerging Company Spotlight report with a performance score of 96.1, highlighting its impact on clinical decision support.
Qualtrics has announced a $6.75 billion acquisition of Press Ganey Forsta, aiming to enhance AI-powered experience management in healthcare.
AstraZeneca has entered a $555 million partnership with Algen Biotechnologies to develop gene-editing therapies using AI and CRISPR technology.
Made Scientific and Streamline Bio have successfully validated Streamline Bio's AI-driven robotics platform in a live cell therapy production environment, as announced in a press release. The collaboration aims to integrate the platform into GMP cleanrooms for commercial-scale implementations.
Halia Therapeutics has appointed Paul Jones as Chief Strategy Officer & GM, International Markets to accelerate its GENMOR-AI platform, according to a press release.
Heidi, a Melbourne-based AI startup, has raised $65 million in a Series B funding round led by Point72 Private Investments, boosting its valuation to $465 million.
A Microsoft-led team discovered that AI-generated toxins can bypass DNA security measures, prompting a call for improved biosecurity protocols.
Embleema, in collaboration with GRAVL and Aria Diagnostics, has been awarded a $5 million contract by the Department of Defense to deploy a biosecurity platform for real-time global pathogen detection.
Community Health Network partners with TripleKey to deploy a real-time risk management platform, addressing rising software vulnerabilities in healthcare.
Twin Health's AI Digital Twin technology has been validated by the Validation Institute for its effectiveness in managing diabetes and related conditions, outperforming traditional care methods.
MedHub-AI has received national reimbursement approval in Japan for its AutocathFFR system, enhancing access to AI-driven coronary physiology assessment.
Aisthesis Medical has raised $1.2 million in pre-seed funding to advance its AI-powered platform for predicting sepsis in hospitals.
ExQor Technologies is preparing for clinical trials of its brain regenerative medicine platform targeting Alzheimer's disease, announced in a press release. The platform shows potential to reverse brain damage and promote regeneration.
AIxMed and Biopticka Laboratoř have signed a Memorandum of Understanding to integrate AIxMed's AIxURO solution into Biopticka's laboratory system, enhancing bladder cancer diagnostics.
OncoC4, a biotechnology company, has closed a Series B financing round of nearly $50 million to advance its pipeline of cancer therapies, announced in a press release.
Psilera Inc. has received a $2 million grant from the National Institutes of Health to advance research on a novel treatment for Alcohol Use Disorder.
Elix, Inc. and Tohoku University have entered a joint research agreement to advance drug discovery using AI technologies, focusing on developing compounds for challenging protein targets.
Kyruus Health has announced a strategic partnership with Healthgrades to improve the digital presence of healthcare providers by streamlining data management and ensuring accurate provider profiles.
SafeTraces has been selected as a Prime Performer for the ARPA-H BREATHE program, leading a $39 million initiative to enhance indoor air quality through real-time biosensors and automated controls.
The Centers for Medicare & Medicaid Services has introduced a new ICD-10-PCS code for AI sepsis diagnostic technologies, including Prenosis' Sepsis ImmunoScore.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
